Back to blogs
This is some text inside of a div block.

Manufactured Blood: How Membio Is Rethinking Supply

August 26, 2026
4 min
Manufactured Blood: How Membio Is Rethinking Supply

TL;DR

  • Manufactured blood aims to create a safer, more reliable red-blood-cell supply without depending entirely on recurring donor availability.
  • Membio describes biomanufactured blood as a way to reduce pathogen risk and address shortages, especially where donation systems cannot meet demand.
  • Shane Kilpatrick says biotech founders should know their customer, prove the technology works, and plan for capital and talent constraints.
  • Scispot's Talk is Biotech series gives founders a direct forum to explain emerging science, market needs, startup barriers, and practical lessons.

Guru sat down with Shane Kilpatrick, CEO at Membio, to talk about Membio's mission of providing the world with safe manufactured blood, its advantages, and much more.

‍

Membio is on a mission to provide the world with a safe and sustainable supply of blood

"Our mission is simple and straightforward. We aim to provide the world with a safe and sustainable supply of blood." - Shane Kilpatrick, CEO at Membio.

‍

Limitations of using regular blood in the healthcare system

Shane points out the limitations of using regular blood in the healthcare system. First and foremost, there's just isn't enough donated blood available in developing nations for clinical purposes, and the donation system is broken. Second, whatever blood is available can be tainted and cause further problems. A safe and sufficient supply of blood will elevate the entire health care system.

‍

Biggest advantage of using biomanufactured blood

Shane points out the significant advantage that biomanufactured blood has. It can guarantee protection against the current and even emerging pathogens. Tainted blood can have catastrophic repercussions. So having a manufactured source can eliminate this problem once and for all.

‍

Barriers that startups like Membio face while getting started

Access to capital and human resources are two of the biggest barriers that startups need to overcome and Shane had to deal with these when he started Membio.

‍

Advice to bioentrepreneurs

Shane's advice to aspiring bioentrepreneurs is simple and effective.

"There are only two questions you need to ask yourself that matter: One, Do you know who your customer is? And Two, does the technology work?." - Shane Kilpatrick, CEO at MemBio.

‍

‍

On this page
Ready to scale?

Run your lab without adding manual work.

See how Scispot connects your workflows, data, and quality processes.

Book a Demo

ArrowRight

Frequently asked questions

What is manufactured blood?

Manufactured blood refers to blood cells or blood components produced outside the traditional donor-supply process. In this interview, Membio focuses on making red blood cells through biomanufacturing. The goal is to provide a safer and more sustainable supply for healthcare systems that face shortages or contamination risk.

Why is Membio working on manufactured blood?

Membio says donated blood is not available in sufficient amounts in many regions and can carry safety risks when collection and screening systems are weak. The company's mission is to create a safe, sustainable supply of blood. Its approach is intended to reduce dependence on donors and improve consistency.

What is the potential advantage of biomanufactured blood?

The interview highlights safety and supply as the main potential advantages. A controlled manufacturing process may reduce exposure to current or emerging pathogens and create a more dependable source. Any product would still need strong evidence, manufacturing control, regulatory review, and clinical validation before broad use.

What challenges do manufactured-blood startups face?

Shane Kilpatrick identifies access to capital and human resources as major barriers. Companies in this field also face complex biology, scale-up, quality control, regulation, clinical evidence, and cost challenges. Building a product that works scientifically is only one part of creating a viable business and supply system.

What advice does Shane Kilpatrick give bioentrepreneurs?

His advice is to answer two questions clearly: do you know who the customer is, and does the technology work? That keeps founders focused on real demand and scientific proof. The interview also shows why access to people and capital must be planned early in a biotech company's development.

Check Out Our Other Blog Posts

View all